
Avelap 250mg Tablet SR
Marketer
Athens Labs Ltd
Salt Composition
Divalproex (250mg)
Overview Avelap 250mg Tablet SR
Epileptic seizures and migraine prophylaxis are key indications for the 250mg sustained-release Avelap tablet. It can also be employed, in some cases, to manage bipolar disorder, either independently or as part of a broader medication regimen. Dosage and frequency are determined individually by your physician to optimize symptom control. Administer at the same time daily, with or without food, for consistent efficacy; therapeutic effects typically manifest within a fortnight. Continuous use, as directed, is crucial; missed doses increase seizure risk, and abrupt cessation may worsen the underlying condition. Gradual discontinuation is essential. Common, usually mild, adverse effects encompass headache, visual disturbances, nausea, vomiting, vertigo, fatigue, instability, easy bruising, and hypothermia. Report persistent or bothersome side effects to your doctor. Seek immediate medical attention for any skin rash or redness. Prolonged use may diminish bone density (osteoporosis), increasing fracture risk. Suicidal ideation and behavior are rare but potential consequences; discuss any mood changes with your physician. Prior to initiating treatment, inform your doctor of any history of cardiovascular disease, hepatic or renal impairment, urinary difficulties, depressive disorders, or suicidal tendencies. Numerous drug interactions are possible; provide a complete medication list to ensure safe co-administration. Pregnant individuals should consult their physician before initiating or discontinuing this medication. Alcohol consumption should be minimized due to the potential for amplified side effects and increased seizure risk. Regular blood tests, pre- and post-treatment, may be necessary to monitor therapeutic levels.
Uses of Avelap 250mg Tablet SR
Managing Epilepsy and Seizures | Bipolar Disorder Therapy | Migraine Prophylaxis
Major Benefits of Avelap 250mg Tablet SR:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Avelap 250mg Sustained-Release Tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Avelap 250mg Tablet SR:
- Decreased body temperature
- Dizziness
- Sleepiness
- Tremors
- Paresthesia (tingling or pricking sensation)
- Anemia (low number of red blood cells)
- Decreased sodium level in blood
- Liver injury
- Gastrointestinal disturbance
- Hypersensitivity
- Deafness
- Urinary incontinence
- Increase in body weight
- Pain during periods
How to use Avelap 250mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 250mg Avelap SR tablet whole; do not break, crush, or chew it. While Avelap 250mg Tablet SR can be taken with or without food, consistent timing is recommended.
How Avelap 250mg Tablet SR works:
Epileptic seizures are managed by Avelap 250mg Sustained-Release tablets, an anticonvulsant drug that reduces heightened, irregular neuronal firing in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Avelap 250mg sustained-release tablets and alcohol can result in significant drowsiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Avelap 250mg tablets pose a confirmed risk to a fetus; therefore, their use during pregnancy is contraindicated. In exceptional, life-threatening circumstances where the potential benefits outweigh the known hazards, a physician might prescribe this medication. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Avelap 250mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Avelap 250mg sustained-release tablets.
KidneySAFE IF PRESCRIBED
Extended-release Avelap 250mg tablets are considered safe for use in individuals with impaired renal function. No alteration of the Avelap 250mg extended-release tablet dosage is advised.
LiverUNSAFE
Extended-release Avelap 250mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is recommended.
What if you forget to take Avelap 250mg Tablet SR :
Should you forget a dose of Avelap 250mg Tablet SR, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Avelap 250mg Tablet SR
| Label | Value |
|---|---|
| Type of Compound | Fatty acid-based compounds |
| Potential for Dependence | None. |
| Type of Medication | Central and peripheral nervous system |
| Mechanism of Action | Anticonvulsant drugs targeting sodium channels |
